71 related articles for article (PubMed ID: 3313782)
1. [Long-term dispensary observation of patients with so-called low-renin forms of arterial hypertension].
Patrusheva IF; Iurenev AP
Ter Arkh; 1987; 59(7):101-3. PubMed ID: 3313782
[TBL] [Abstract][Full Text] [Related]
2. [Long-term ambulatory follow-up of hypertension patients with low renin activity in blood].
Iurenev AP; Patrusheva IF
Ter Arkh; 2002; 74(9):57-9. PubMed ID: 12418122
[TBL] [Abstract][Full Text] [Related]
3. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
[TBL] [Abstract][Full Text] [Related]
4. Determination of the aldosterone/renin ratio in 269 patients with adrenal incidentaloma.
Vierhapper H
Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):518-21. PubMed ID: 17853335
[TBL] [Abstract][Full Text] [Related]
5. Pathology of the adrenal gland in refractory low-renin hypertension.
Longo DL; Esterly JA; Grim CE; Keitzer WF
Arch Pathol Lab Med; 1978 Jun; 102(6):322-7. PubMed ID: 580727
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
[TBL] [Abstract][Full Text] [Related]
7. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
8. [Some approaches to the treatment of hypertension, refractory to hypotensive agents].
Nekrasova AA; Chernova NA; Patrusheva IF; Dzhusipov AK; Chikhladze NM
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):35-8. PubMed ID: 6639755
[TBL] [Abstract][Full Text] [Related]
9. [The influence of adrenalectomy on the treatment of arterial hypertension in patients with benign adrenal medullary and cortical tumors].
Ziaja JM; Cierpka LD; Król RJ; Gasińska TE; Tuszyński GJ; Cholewa KW; Kajor MW
Wiad Lek; 2003; 56(11-12):545-51. PubMed ID: 15058162
[TBL] [Abstract][Full Text] [Related]
10. Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
Biglieri EG; Kater CE; Arteaga EE
J Hypertens Suppl; 1984 Dec; 2(3):S259-61. PubMed ID: 6599673
[TBL] [Abstract][Full Text] [Related]
11. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
Mahmud A; Mahgoub M; Hall M; Feely J
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
[TBL] [Abstract][Full Text] [Related]
12. Endocrine arterial hypertension: therapeutic approach in clinical practice.
Mazza A; Armigliato M; Zamboni S; Rempelou P; Rubello D; Pessina AC; Casiglia E
Minerva Endocrinol; 2008 Dec; 33(4):297-312. PubMed ID: 18923367
[TBL] [Abstract][Full Text] [Related]
13. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone and refractory hypertension: a prospective cohort study.
Sartori M; Calò LA; Mascagna V; Realdi A; Macchini L; Ciccariello L; De Toni R; Cattelan F; Pessina AC; Semplicini A
Am J Hypertens; 2006 Apr; 19(4):373-9; discussion 380. PubMed ID: 16580572
[TBL] [Abstract][Full Text] [Related]
15. [Primary hyperaldosteronism--12 clinical cases].
Telles EC; Machado FS; da Silva EP; Lutucuta S; Almeida G; Coucelo J; Vagueiro C
Rev Port Cardiol; 1999 Sep; 18(9):801-12. PubMed ID: 10536470
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the hypotensive effect of unilateral adrenalectomy in patients with low-renin hyperaldosteronism].
Ustinova SE; Shkhvatsabaia IK; Pokrovskiĭ AV; Kazanchian PO; Sokolova RI
Ter Arkh; 1987; 59(9):21-6. PubMed ID: 3321517
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.
Pang TC; Bambach C; Monaghan JC; Sidhu SB; Bune A; Delbridge LW; Sywak MS
ANZ J Surg; 2007 Sep; 77(9):768-73. PubMed ID: 17685956
[TBL] [Abstract][Full Text] [Related]
18. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
Kreeft JH; Larochelle P; Ogilvie RI
Can Med Assoc J; 1983 Jan; 128(1):31-4. PubMed ID: 6336600
[TBL] [Abstract][Full Text] [Related]
19. Physiologic tailoring of therapy for resistant hypertension: 20 years' experience with stimulated renin profiling.
Spence JD
Am J Hypertens; 1999 Nov; 12(11 Pt 1):1077-83. PubMed ID: 10604483
[TBL] [Abstract][Full Text] [Related]
20. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
